Howard D. Homesley, MD

HOWARD D. HOMESLEY, MD

Brody 2S-12
Greenville, NC 27834

Phone:	744-3587
Fax:	744-3459
E-mail:	homesleyh@ecu.edu

Position


	Faculty Rank: Clinical Professor, Director of Obstetrics and Gynecology

	Primary Specialty: Obstetrics and Gynecology

	Secondary Specialty: Gynecologic Oncology

	Interests/Skills: Clinical Investigations in All Aspects of Gynecologic Oncology

	Year Started at ECU: 2004

Education


	Board Certification: Obstetrics and Gynecology (2003)

	Residency/Internship: Vanderbilt University School of Medicine, Nashville, TN (1967-1971)

	Medical School: University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC (1967)

SCHOLARLY ACTIVITIES

Abstracts | Articles | Publications | Presentations

Abstracts

Line Therapy of Epithelial Ovarian Carcinoma. Proc. ASCO, 19, 395a, 2000.

Homesley H, Blessing J, Sorosky J, Reid G, Look K. Liposomal Doxorubicin Every Four Weeks in Endometrial Carcinoma, A Gynecologic Oncology Study, Proc. ASCO, 2005.


	return to Scholarly Activities

Articles

Homesley HD, Hall DJ, Martin DA, Lewandowski GS, Vaccarello L, Nahhas WA, Suggs CL, Penley RG A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients. Gynecol Oncol. 2001 Nov; 83(2): 394-9.

Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2001 Jan 15; 19(2): 364-7.

Homesley H, Benigno B, Williams J, Vaccarello L. A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Ovarian Carcinoma Patients. Gynecol Oncol. 2002 Nov: 87 (2): 171-177.

Homesley HD, Boike G., Spiegel GW Feasibility of Laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study. Int. Gynecol Cancer. 2004 14, 1-7

Tate Thigpen J, Blessing JA, DeGeest K, Look KY, Homesley HD; Gynecologic Oncology Group. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.Gynecol Oncol. 2004 May; 93 (2): 336-9.

Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol. 2004 Oct 1; 22 (19): 3902-8.


	Non-Peer Review Articles Homesley HD, Muss HB. A Role of Chemotherapy Dose Intensification in the Treatment of Advanced Ovarian Cancer. @ Review. Oncology. 1995: 9; 992. Homesley HD. “Clinical Opinion: Management of Endometrial Cancer.” Amer. J. of Obstet. Gynec. 1995:174; 529-534. Homesley HD. Management of Vulvar Cancer. Cancer. 1995; 76 (10 Suppl): 2159-70. Homesley HD. Management of Endometrial Cancer. American Journal of Obstet Gynecol. 1996:174 (2): 529-34. Homesley HD. Single Agent Therapy of Nonmetastatic and Low Risk Gestational Trophoblastic Disease. Editors: Berkowitz RS, Goldstein DP. Symposium on Gestational Trophoblastic Disease. J. of Reprod. Med. 1998; 43:69-74.

	return to Scholarly Activities

Publications

Homesley HD. Treatment of Non-Metastatic Gestational Trophoblastic Disease. In: Hancock B, Ed. Gestational Trophoblastic Disease. 2nd Edition London, UK: Chapman and Hall. 2003; 293-304.

Homesley HD and Manneta A. Cancer of the Uterine Corpus. In: Manneta A, Eds. Cancer Prevention and Early Diagnosis in Women. Philadelphia, PA. Mosby. 2003; 267-288.

Homesley HD. Combined Therapy. In: Luesley D and Lawton F, Eds. Uterine Cancer. New York, NY. Marcel Dekker, Inc. In Press.


	return to Scholarly Activities

Presentations

“Weekly Topotecan,” Audiotape, New York, New York, July 13, 2002.

“Dose Finding Study of Weekly Topotecan and Weekly Paclitaxel for Advanced Ovarian Cancer," Society of Memorial Gynecologic Oncology, New York, New York, September 19, 2002.

“Monoclonal Antibody Trials in Ovarian Cancer,” Seccion de Ginecologia Oncologica of the Sociedad Espanola de Ginecologia Y Obstetricia, Valladolid, Spain, October 9, 2002.

“Vulvar lesions and Vulvar Cancer,” 33rd Annual Autumn Seminar in Obstetrics and Gynecology, University of Minnesota, Minneapolis, Minnesota, October 28, 2002.

“Incorporating Clinical Trials into Your Busy Practice,” 34th Annual Meeting of the Society of Gynecologic Oncology, New Orleans, LA, January 31, 2003.

“Conducting Clinical Trials—Pros and Cons,” 35th Annual Meeting of the Society of Gynecologic Oncology, San Diego, CA, February 11, 2004.

“Hormonal Management of Disseminated Endometrial Carcinoma,” International Symposium on Gyn Malignancies, New York, New York, April 17. 2004.

“Evaluation and Treatment of Abnormal Pap Smears and HPV Infections,” New Perspectives in Gynecologic Oncology, Alexian Brothers Medical Center, Chicago, Illinois, October 2, 2004.

“Update on GOG Protocols.” New Perspectives in Gynecologic Oncology," Alexian Brothers Medical Center, Chicago, Illinois, October 2, 2004.

“Advances in Treatment of Disseminated Endometrial Cancer.” Meet the Experts, Society of Gyn Oncology, Miami, FL March 19, 2005.


	return to Scholarly Activities